FOI release

FOI2021/00428: Drug SNG001

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2021/00428

Published 2 December 2021

Request

Request Received: 16 September 2021

I would like information on a drug SNG001 made by a company called Synairgen. I was surprised to see that this hasn't been included on your website despite applications to be included.

I would therefore like any information why the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP) hasn't endorsed inhaled interferon beta drug (SNG001) and the reasons for the rejected.

Response

Response Sent: 27 September 2021

Full details of this response are provided in the attached document.

Documents

This is UK Research and Innovation's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.